Envision Healthcare (NYSE: EVHC) has recently received a number of price target changes and ratings updates:

  • 7/7/2017 – Envision Healthcare was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “Envision Healthcare Corporation is optimistic about the consolidating physician services market. It had an active start to the acquisition strategy for 2017, having completed four acquisitions in Physician Services in Jan 2017 and the buyout of Imaging Advantage LLC, in Apr 2017. The company is in the process of selling its once indispensable medical transportation business American Medical Response (AMR) to focus on physician staffing. The company, however, suffers from high indebtedness. It has about 4.3 times EBITDA, which is above the 3 to 4 times EBITDA that the company feels comfortable at. Also, its operating expense is on the rise and exceeding revenue growth. The company’s shares have underperformed the Zacks categorized Medical Outpatient and Home Healthcare industry, year to date.”
  • 7/4/2017 – Envision Healthcare was upgraded by analysts at Zacks Investment Research from a “strong sell” rating to a “buy” rating. They now have a $70.00 price target on the stock. According to Zacks, “Envision Healthcare Corporation is optimistic about the consolidating physician services market. It had an active start to the acquisition strategy for 2017, having completed four acquisitions in Physician Services in Jan 2017 and the buyout of Imaging Advantage LLC, in Apr 2017. The company is in the process of selling its once indispensable medical transportation business American Medical Response (AMR) to focus on physician staffing. The company, however, suffers from high indebtedness. It has about 4.3 times EBITDA, which is above the 3 to 4 times EBITDA that the company feels comfortable at. Also, its operating expense is on the rise and exceeding revenue growth. The company’s shares have underperformed the Zacks categorized Medical Outpatient and Home Healthcare industry, year to date.”
  • 7/4/2017 – Envision Healthcare had its “buy” rating reaffirmed by analysts at Cantor Fitzgerald. They now have a $80.00 price target on the stock.
  • 6/27/2017 – Envision Healthcare had its price target raised by analysts at Royal Bank Of Canada from $72.00 to $77.00. They now have an “outperform” rating on the stock.
  • 6/17/2017 – Envision Healthcare was upgraded by analysts at BidaskClub from a “sell” rating to a “hold” rating.
  • 6/5/2017 – Envision Healthcare had its “buy” rating reaffirmed by analysts at Royal Bank Of Canada. They now have a $72.00 price target on the stock.
  • 5/30/2017 – Envision Healthcare had its price target lowered by analysts at Mizuho from $70.00 to $60.00. They now have a “neutral” rating on the stock.

Envision Healthcare Co. (NYSE EVHC) traded down 0.75% during midday trading on Tuesday, hitting $61.19. 83,406 shares of the stock were exchanged. Envision Healthcare Co. has a 1-year low of $53.12 and a 1-year high of $80.01. The stock’s market cap is $7.10 billion. The company’s 50 day moving average is $57.27 and its 200-day moving average is $62.64.

Envision Healthcare (NYSE:EVHC) last issued its earnings results on Tuesday, May 2nd. The company reported $0.69 EPS for the quarter, hitting the consensus estimate of $0.69. Envision Healthcare had a negative net margin of 9.16% and a positive return on equity of 5.75%. The company had revenue of $1.88 billion for the quarter, compared to the consensus estimate of $2.52 billion. On average, analysts expect that Envision Healthcare Co. will post $1.40 earnings per share for the current year.

In related news, insider Robert Jon Coward sold 1,500 shares of Envision Healthcare stock in a transaction on Thursday, June 22nd. The shares were sold at an average price of $60.00, for a total value of $90,000.00. Following the sale, the insider now owns 99,363 shares in the company, valued at $5,961,780. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In the last quarter, insiders sold 4,500 shares of company stock worth $274,830. 3.10% of the stock is currently owned by company insiders.

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

Receive News & Ratings for Envision Healthcare Co Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Co and related companies with MarketBeat.com's FREE daily email newsletter.